Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.

Selvaraj S, Klein I, Danzi S, Akhter N, Bonow RO, Shah SJ.

Am J Cardiol. 2012 Jul 15;110(2):234-9. doi: 10.1016/j.amjcard.2012.02.068.

2.

Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction.

Selvaraj S, Ilkhanoff L, Burke MA, Freed BH, Lang RM, Martinez EE, Shah SJ.

J Am Soc Echocardiogr. 2014 Jan;27(1):74-82.e2. doi: 10.1016/j.echo.2013.08.023.

3.

Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.

Ishigaki T, Yoshida T, Izumi H, Fujisawa Y, Shimizu S, Masuda K, Asanuma T, Okabe H, Nakatani S.

Echocardiography. 2015 Apr;32(4):623-9. doi: 10.1111/echo.12707.

PMID:
25115860
4.

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.

van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL.

J Am Coll Cardiol. 2013 Apr 9;61(14):1498-506. doi: 10.1016/j.jacc.2012.12.044.

5.

Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction.

Anjan VY, Loftus TM, Burke MA, Akhter N, Fonarow GC, Gheorghiade M, Shah SJ.

Am J Cardiol. 2012 Sep 15;110(6):870-6. doi: 10.1016/j.amjcard.2012.05.014.

6.

Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.

Yu CM, Sanderson JE, Shum IO, Chan S, Yeung LY, Hung YT, Cockram CS, Woo KS.

Eur Heart J. 1996 Nov;17(11):1694-702.

7.

B-type natriuretic peptide as a biochemical marker of left ventricular diastolic function: assessment in asymptomatic patients 1 year after valve replacement for aortic stenosis.

Mannacio V, Antignano A, De Amicis V, Di Tommaso L, Giordano R, Iannelli G, Vosa C.

Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):371-7. doi: 10.1093/icvts/ivt186.

8.
9.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048.

PMID:
18773998
10.

Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B-type natriuretic peptide.

Popescu BA, Popescu AC, Antonini-Canterin F, Rubin D, Cappelletti P, Piazza R, Ginghina C, Dimulescu D, Beladan CC, Nicolosi GL.

Echocardiography. 2007 Nov;24(10):1035-43.

PMID:
18001356
11.

The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.

Kim H, Jun DW, Cho YK, Nam CW, Han SW, Hur SH, Kim YN, Kim KB.

Echocardiography. 2008 Oct;25(9):961-7. doi: 10.1111/j.1540-8175.2008.00717.x.

PMID:
18771554
13.

BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.

Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H.

Eur J Heart Fail. 2008 Mar;10(3):252-9. doi: 10.1016/j.ejheart.2008.01.017.

14.

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.

Persson H, Lonn E, Edner M, Baruch L, Lang CC, Morton JJ, Ostergren J, McKelvie RS; Investigators of the CHARM Echocardiographic Substudy-CHARMES..

J Am Coll Cardiol. 2007 Feb 13;49(6):687-94.

15.
16.

Systolic and diastolic heart failure in the community.

Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL.

JAMA. 2006 Nov 8;296(18):2209-16.

PMID:
17090767
17.

Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.

Brucks S, Little WC, Chao T, Kitzman DW, Wesley-Farrington D, Gandhi S, Shihabi ZK.

Am J Cardiol. 2005 Mar 1;95(5):603-6.

PMID:
15721099
18.

Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.

Kasner M, Aleksandrov AS, Westermann D, Lassner D, Gross M, von Haehling S, Anker SD, Schultheiss HP, Tschöpe C.

Int J Cardiol. 2013 Oct 12;168(5):4652-7. doi: 10.1016/j.ijcard.2013.07.185.

PMID:
23968714
19.

Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.

Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, Yandle TG, Richards AM, Starling RC, Young JB, Thomas JD, Klein AL.

J Am Coll Cardiol. 2004 Feb 4;43(3):416-22.

20.

Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study.

Jaubert MP, Armero S, Bonello L, Nicoud A, Sbragia P, Paganelli F, Arques S.

Arch Cardiovasc Dis. 2010 Jan;103(1):3-9. doi: 10.1016/j.acvd.2009.10.005.

Items per page

Supplemental Content

Support Center